We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




U.S. Manufacture of I-131 Renewed after 30 Years

By MedImaging International staff writers
Posted on 05 Dec 2018
Print article
Image: MURR is the only supplier of I-131 in the United States (Photo courtesy of University of Missouri).
Image: MURR is the only supplier of I-131 in the United States (Photo courtesy of University of Missouri).
The University of Missouri Research Reactor (MURR; Columbia, MO, USA) recently shipped the first batch of Iodine-131 (I-131), a critical radioisotope used for diagnoses and treatment of thyroid cancer and hyperthyroidism. The shipment makes MURR the first U.S. supplier of I-131 since the 1980s, and the only supplier currently in the United States.

I-131 sodium iodide is one of the most widely used radiopharmaceuticals in the United States. Since the thyroid gland naturally absorbs iodine, I 131 can be used to directly target thyroid tumors in order to destroy the cancerous tissue. But with only an eight-day half-life, stockpiling I-131 is impossible and logistics become complicated, making a reliable supplier critical for patients. MURR thus joins the handful of research reactors around the world that supply I-131 to manufacturers who, in turn, supply radiopharmaceuticals for distribution to hospitals and patients.

“This summer there was an international shortage of I-131, just as we were turning on the reactor. We were asked to ramp up our production faster, but I wasn't willing to do so. You have to make sure you know what you're doing,” said David Robertson, PhD, executive director of MURR. “Now we're slowly ramping up as we gain experience. Supplying I 131 is part of a strategic initiative by the University of Missouri and MURR to address medical isotope shortages and further the University’s research mission.”

“Having MURR as a domestic producer for I-131 provides a much higher level of stability and reliability in the U.S. for this important isotope,” said Steve Laflin, president and CEO of International Isotopes (INIS; Idaho Falls, ID, USA). “INIS has been supplying I-131 throughout the U.S. for nearly 15 years using only foreign sources of supply. We are pleased to have an opportunity to enter into a long-term supply agreement, and INIS plans to utilize MURR as one of our major suppliers for I-131 in the future.”

The thyroid is an endocrine gland located in the neck that produces two hormones secreted into the bloodstream, thyroxine (T4) and triiodothyronine (T3); T4 is converted to T3 in cells and tissues. The hormones regulate metabolism. Thyroid disorders include hypothyroidism, hyperthyroidism, nodules, cancer, Graves disease, and post-partum thyroiditis. Most disorders tend to occur mainly in women.

Related Links:
University of Missouri Research Reactor
International Isotopes

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Area Product Meter
VacuDAP
Digital Radiography Acquisition Software
VXvue with PureImpact
MRI System
uMR 588

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.